Desloratadine

🧮 Dose calculator

Allergic rhinitis · Regimen source: UK SmPC Neoclarityn · 4.2UK SmPC Neoclarityn · 4.1

• • Most rhinitis under 2 years is infectious; no data for infectious rhinitis. Safety below 1 year not established. UK SmPC Neoclarityn · 4.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Desloratadine · 8.1

  “Risk Summary The limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Desloratadine · 8.2

  “Risk Summary Desloratadine passes into breast milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Desloratadine · 8.4

  “The recommended dose of desloratadine oral solution in the pediatric population is based on cross-study comparison of the plasma concentration of desloratadine in adults and pediatric subjects.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Desloratadine · 8.5

  “In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Desloratadine · 8.3

  “Infertility There are no data available on human infertility associated with desloratadine.”